ClinicalTrials.Veeva

Menu

Examining the Individual Response to a Restricted Sodium Diet in Hypertensive Patients

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Hypertension

Treatments

Behavioral: Usual care + Digital Self-Monitoring
Behavioral: Modified Sodium Watcher Program + Digital Self-Monitoring

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04764253
HSC20200504H
KL2TR002646 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Excessive dietary sodium intake is an independent risk factor for hypertension and cardiovascular disease. A vast array of efforts have tried to reduce sodium consumption based on evidence indicating a public health benefit. Yet this benefit has been questioned, mainly based on studies showing variability in individual responses to a sodium-restricted diet (SRD). The effects of an SRD on blood pressure vary, and adherence to an SRD is not optimal. The original Sodium Watchers Program (R01NR012967) was developed and implemented by Dr. Misook Chung (University of Kentucky). In this pilot study, the modified Sodium Watchers Program will propose improving adherence to an SRD through education and digital self-monitoring for daily sodium intake and blood pressure.

In addition, few studies have examined individuals' metabolic responses to the SRD. In a secondary analysis, we further will examine genetic variants associated with salt sensitivity and whether such a genetic component is associated with sodium excretion and BP control.

A total of 40 hypertensive patients will be randomly assigned to the intervention (n=20) or control group (n=20). The intervention group will receive 8-week education sessions remotely using a video conferencing program. All participants will collect a 24-hour urine specimen for sodium excretion and a total of 4.0ml of peripheral blood will be drawn for salt sensitivity during baseline visit. All participants will be asked to log their activities in real-time, including food intake and in-home BP monitoring using Fitbit and accompanied mobile app and BP monitor.

Enrollment

40 patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Systolic blood pressure of 120-159 mmHg or diastolic blood pressure of 80-99 mmHg, whether or not taking blood pressure medications.
  • Smartphone with a data plan
  • Valid email address
  • Willing and able to participate in online study videoconferencing visits (Zoom)
  • Reads and writes in English

Exclusion criteria

  • Participating in another related research study
  • Cardiovascular disease event (e.g. stroke, myocardial infarction) in prior 6 months
  • Active cancer
  • Recent hospitalization due to psychiatric condition or event
  • Pregnancy or breastfeeding - current or planned during the study period
  • Documented dementia
  • Prisoners
  • Diabetes Diagnosis
  • Heart Failure Diagnosis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Modified Sodium Watcher Program + Digital Self-Monitoring
Experimental group
Treatment:
Behavioral: Modified Sodium Watcher Program + Digital Self-Monitoring
Usual care + Digital Self-Monitoring
Active Comparator group
Treatment:
Behavioral: Usual care + Digital Self-Monitoring

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Jisook Ko, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems